Antivirals in medical biodefense von Bugert, J. J., Hucke, F., Zanetta, P., Bassetto, M., Brancale, A.

Volltext

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib von Pinter, M., Sieghart, W., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weissmann, A., Kornek, G., Matejka, J., Stauber, R., Buder, R., Grünberger, B., Schöniger‐Hekele, M., Müller, C., Peck‐Radosavljevic, M.

Volltext

P0385 : Prognostic impact of the Baveno IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma von Hucke, F, Pachta, E, Reiberger, T, Mandorfer, M, Sieghart, W, Peck-Radosavljevic, M

Volltext

Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients von Purevsambuu, T, Bota, S, Hucke, F, Hofer, H, Ferenci, P, Sieghart, W, Peck-Radosavljevic, M

Volltext

P1280 EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN AUSTRIA von Pinter, M, Hucke, F, Zielonke, N, Trauner, M, Peck-Radosavljevic, M, Sieghart, W

Volltext

P0362 : Hepatocellular carcinoma incidence in chronic hepatitis C patients according to antiviral treatment status von Purevsambuu, T, Bota, S, Hucke, F, Hofer, H, Ferenci, P, Sieghart, W, Peck-Radosavljevic, M

Volltext

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients von Bota, S, Purevsambuu, T, Hucke, F, Reiberger, T, Ferlitsch, A, Hofer, H, Sieghart, W, Peck-Radosavljevic, M

Volltext

O055 : Pushing the limits for tace: Selection for transarterial chemoembolisation treatment (state) score identifies HCC patients at BCLC stage C suitable for tace von Hucke, F, Pinter, M, Graziadei, I, Bota, S, Vogel, W, Millier, C.J, Wanek, F, Trauner, M, Peck-Radosavljevic, M, Sieghart, W

Volltext

983 INCIDENCE AND MORTALITY TRENDS FOR BILIARY TRACT CANCERS IN AUSTRIA von Pinter, M, Hucke, F, Trauner, M, Peck-Radosavljevic, M, Sieghart, W

Volltext

O129 VALIDATION OF THE BCLC-B SUBCLASSIFICATION IN AN AUSTRIAN TACE COHORT von Hucke, F, Pinter, M, Graziadei, I, Vogel, W, Trauner, M, Sieghart, W, Peck-Radosavljevic, M

Volltext

O125 HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C PATIENTS (CHC) ACCORDING TO SUSTAINED VIROLOGIC RESPONSE (SVR) AND BASELINE CHARACTERISTICS von Purevsambuu, T, Bota, S, Hucke, F, Hofer, H, Ferenci, P, Sieghart, W, Peck-Radosavljevic, M

Volltext

P983 VALIDATION OF THE HEPATOME ARTERIAL-EMBOLIZATION PROGNOSTIC (HAP)-SCORE IN AN AUSTRIAN TACE COHORT von Pinter, M, Hucke, F, Graziadei, I, Vogel, W, Trauner, M, Sieghart, W, Peck-Radosavljevic, M

Volltext

102 THE ART OF DECISION MAKING: RETREATMENT WITH TACE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA von Sieghart, W, Hucke, F, Pinter, M, Graziadei, I, Vogel, W, Müller, C, Heinzl, H, Trauner, M, Peck-Radosavljevic, M

Volltext

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species von Siefert, H M, Domdey-Bette, A, Henninger, K, Hucke, F, Kohlsdorfer, C, Stass, H H

Volltext

656 OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION von Sieghart, W, Pinter, M, Graziadei, I, Hucke, F, Rasoul-Rockenschaub, S, Stauber, R, Wagner, D, Vogel, W, Peck-Radosavljevic, M

Volltext

FRI-153 - The impact of platelets on patients with hepatocellular carcinoma von Scheiner, B., Popp, S., Hucke, F., Bota, S., Peck, M., Rohr-Udilova, N., Reiberger, T., Müller, C., Trauner, M., Sieghart, W., Pinter, M.

Volltext

The impact of platelets on patients with hepatocellular carcinoma von Scheiner, B., Popp, S., Hucke, F., Bota, S., Peck, M., Rohr-Udilova, N., Reiberger, T., Müller, C., Trauner, M., Sieghart, W., Pinter, M.

Volltext

THU-099 - Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients von Purevsambuu, T., Bota, S., Hucke, F., Hofer, H., Ferenci, P., Sieghart, W., Peck-Radosavljevic, M.

Volltext

Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response-based approach von Han, G, Berhane, S, Toyoda, H, Bettinger, D, Elshaarawy, O, Chan, AWH, Kirstein, M, Mosconi, C, Hucke, F, Palmer, D, Pinato, DJ, Sharma, R, Ottaviani, D, Jang, JW, Labeur, TA, Van Delden, OM, Pirisi, M, Stern, N, Sangro, B, Meyer, T, Fateen, W, García-Fiñana, M, Gomaa, A, Waked, I, Rewisha, E, Aithal, GP, Travis, S, Kudo, M, Cucchetti, A, Peck-Radosavljevic, M, Takkenberg, RB, Chan, SL, Vogel, A, Johnson, PJ

Volltext

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy von Pinter, M., Sieghart, W., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weissmann, A., Kornek, G., Matejka, J., Stauber, R., Buder, R., Grünberger, B., Schöniger-Hekele, M., Müller, C., Peck-Radosavljevic, M.

Volltext